becton dickinson and co (BDX) Key Developments
Retractable Technologies Announces U.S. Supreme Court Decision on Denial of Writ of Certiorari
Apr 22 15
Retractable Technologies Inc. announced that on April 20, 2015, the Supreme Court of the United States denied the petition for a writ of certiorari by Becton, Dickinson and Company (BD) relating to its Rule 60(b) motion in the portion of Retractable's case against BD addressing patent infringement claims. The patent claims were severed from Retractable's other claims against BD in 2008. The other portion of the case in which the District Court granted Retractable a final judgment for $352 million plus other relief is not directly affected by the recent Supreme Court ruling.
Becton, Dickinson Reportedly Looks To Sell Respiratory Device Unit
Mar 25 15
Becton, Dickinson and Company (NYSE:BDX) is reportedly planning to sell its respiratory-devices unit according to people with knowledge of the matter. Becton, Dickinson is looking to sell unwanted assets following its acquisition of CareFusion Corp. “We’re conducting a strategic review of all of our businesses but haven’t made any decisions,” said Kristen Cardillo, a spokeswoman for Becton Dickinson.
Becton, Dickinson and Company and CareFusion Corporation Receives Clearance from the European Commission for the Pending Acquisition
Mar 13 15
Becton, Dickinson and Company and CareFusion Corporation announced that the companies have received clearance from the European Commission under the EU Merger Regulation for the pending acquisition of CareFusion by BD. The proposed acquisition has now received all necessary regulatory approvals. The proposed acquisition, which has been approved by CareFusion shareholders, remains subject to customary closing conditions. BD and CareFusion currently expect the proposed acquisition to close on March 17, 2015.
Becton, Dickinson and Company Presents at Barclays Global Healthcare Conference, Mar-10-2015 11:15 AM
Mar 3 15
Becton, Dickinson and Company Presents at Barclays Global Healthcare Conference, Mar-10-2015 11:15 AM. Venue: Loews Miami Beach Hotel, 1601 Collins Avenue, Miami, Florida, United States. Speakers: Christopher R. Reidy, Chief Financial Officer and Executive Vice President of Administration.
Becton, Dickinson and Company Announces Consolidated Unaudited Earnings Results for the First Quarter Ended December 31, 2014; Provides Earnings Guidance for the Full Year of Fiscal 2015
Feb 5 15
Becton, Dickinson and Company announced consolidated unaudited earnings results for the first quarter ended December 31, 2014. For the quarter, the company reported revenues of $2,051 million compared with $2,015 million for the same period a year ago. Operating income was $349 million compared with $378 million for the same period a year ago. Income before tax was $236 million compared with $271 million for the same period a year ago. Net income was $236 million or $1.20 per diluted share compared with $271 million or $1.37 per diluted share for the same period a year ago. Adjusted diluted earnings per share was $1.53 compared with $1.43 for the same period a year ago.
The company estimates that revenues for the full fiscal year 2015 will increase approximately 5.0% on a foreign currency-neutral basis, which is an increase from previously issued guidance of 4.5% to 5%. On a reported basis, revenues are expected to be about flat to a decline of 1.0%, due to the unfavorable impact of foreign currency. The company expects adjusted diluted earnings per share from continuing operations to grow 9.0% to 10.0% on a foreign currency-neutral basis. This is an increase from previously issued guidance of 8.0% to 9.0%. Including the estimated unfavorable impact of foreign-currency, adjusted diluted earnings per share are expected to be between $6.50 and $6.57. Adjusted diluted earnings per share for the full fiscal year 2014 were $6.50. The company expects full fiscal year reported diluted earnings per share from continuing operations to be between $5.98 to $6.05.